The software is artificial intelligence-based, composed of automated DR screening and mobile or hardware components. The goal is to bring long term and cheap diabetic retinopathy screening to diabetic patients through ML or mobile phones. The core technique for the analysis is deep learning module, and with the web interfaces, both doctors and patients could visually understand the results.
Market Analysis and Insights: Global Diabetic Retinopathy (DR) Analysis Software Market
The global Diabetic Retinopathy (DR) Analysis Software market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Diabetic Retinopathy (DR) Analysis Software is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Diabetic Retinopathy (DR) Analysis Software is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Diabetic Retinopathy (DR) Analysis Software is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Diabetic Retinopathy (DR) Analysis Software include Evolucare, IDx Technologies Inc., Yingtong, Vistel, MONA and Eyenuk, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Diabetic Retinopathy (DR) Analysis Software market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Diabetic Retinopathy (DR) Analysis Software, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Diabetic Retinopathy (DR) Analysis Software, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Diabetic Retinopathy (DR) Analysis Software revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Diabetic Retinopathy (DR) Analysis Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Diabetic Retinopathy (DR) Analysis Software revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Evolucare, IDx Technologies Inc., Yingtong, Vistel, MONA and Eyenuk, etc.
By Company
Evolucare
IDx Technologies Inc.
Yingtong
Vistel
MONA
Eyenuk
Segment by Type
AI Screening System
AI Analysis (Disease Assessment)
Segment by Application
Clinical Diagnoses
Personal Triage
Investigational Use
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Diabetic Retinopathy (DR) Analysis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Retinopathy (DR) Analysis Software companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetic Retinopathy (DR) Analysis Software revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 AI Screening System
1.2.3 AI Analysis (Disease Assessment)
1.3 Market by Application
1.3.1 Global Diabetic Retinopathy (DR) Analysis Software Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Clinical Diagnoses
1.3.3 Personal Triage
1.3.4 Investigational Use
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Retinopathy (DR) Analysis Software Market Perspective (2018-2029)
2.2 Global Diabetic Retinopathy (DR) Analysis Software Growth Trends by Region
2.2.1 Diabetic Retinopathy (DR) Analysis Software Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Region (2018-2023)
2.2.3 Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Region (2024-2029)
2.3 Diabetic Retinopathy (DR) Analysis Software Market Dynamics
2.3.1 Diabetic Retinopathy (DR) Analysis Software Industry Trends
2.3.2 Diabetic Retinopathy (DR) Analysis Software Market Drivers
2.3.3 Diabetic Retinopathy (DR) Analysis Software Market Challenges
2.3.4 Diabetic Retinopathy (DR) Analysis Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Diabetic Retinopathy (DR) Analysis Software by Players
3.1.1 Global Diabetic Retinopathy (DR) Analysis Software Revenue by Players (2018-2023)
3.1.2 Global Diabetic Retinopathy (DR) Analysis Software Revenue Market Share by Players (2018-2023)
3.2 Global Diabetic Retinopathy (DR) Analysis Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Diabetic Retinopathy (DR) Analysis Software, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Diabetic Retinopathy (DR) Analysis Software Market Concentration Ratio
3.4.1 Global Diabetic Retinopathy (DR) Analysis Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy (DR) Analysis Software Revenue in 2022
3.5 Global Key Players of Diabetic Retinopathy (DR) Analysis Software Head office and Area Served
3.6 Global Key Players of Diabetic Retinopathy (DR) Analysis Software, Product and Application
3.7 Global Key Players of Diabetic Retinopathy (DR) Analysis Software, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Retinopathy (DR) Analysis Software Breakdown Data by Type
4.1 Global Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Type (2018-2023)
4.2 Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Type (2024-2029)
5 Diabetic Retinopathy (DR) Analysis Software Breakdown Data by Application
5.1 Global Diabetic Retinopathy (DR) Analysis Software Historic Market Size by Application (2018-2023)
5.2 Global Diabetic Retinopathy (DR) Analysis Software Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Diabetic Retinopathy (DR) Analysis Software Market Size (2018-2029)
6.2 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Type
6.2.1 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2018-2023)
6.2.2 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2024-2029)
6.2.3 North America Diabetic Retinopathy (DR) Analysis Software Market Share by Type (2018-2029)
6.3 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Application
6.3.1 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2018-2023)
6.3.2 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2024-2029)
6.3.3 North America Diabetic Retinopathy (DR) Analysis Software Market Share by Application (2018-2029)
6.4 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country
6.4.1 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2018-2023)
6.4.3 North America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Diabetic Retinopathy (DR) Analysis Software Market Size (2018-2029)
7.2 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Type
7.2.1 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2018-2023)
7.2.2 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2024-2029)
7.2.3 Europe Diabetic Retinopathy (DR) Analysis Software Market Share by Type (2018-2029)
7.3 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Application
7.3.1 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2018-2023)
7.3.2 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2024-2029)
7.3.3 Europe Diabetic Retinopathy (DR) Analysis Software Market Share by Application (2018-2029)
7.4 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country
7.4.1 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2018-2023)
7.4.3 Europe Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Diabetic Retinopathy (DR) Analysis Software Market Size (2018-2029)
8.2 China Diabetic Retinopathy (DR) Analysis Software Market Size by Type
8.2.1 China Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2018-2023)
8.2.2 China Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2024-2029)
8.2.3 China Diabetic Retinopathy (DR) Analysis Software Market Share by Type (2018-2029)
8.3 China Diabetic Retinopathy (DR) Analysis Software Market Size by Application
8.3.1 China Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2018-2023)
8.3.2 China Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2024-2029)
8.3.3 China Diabetic Retinopathy (DR) Analysis Software Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Diabetic Retinopathy (DR) Analysis Software Market Size (2018-2029)
9.2 Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Type
9.2.1 Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2018-2023)
9.2.2 Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2024-2029)
9.2.3 Asia Diabetic Retinopathy (DR) Analysis Software Market Share by Type (2018-2029)
9.3 Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Application
9.3.1 Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2018-2023)
9.3.2 Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2024-2029)
9.3.3 Asia Diabetic Retinopathy (DR) Analysis Software Market Share by Application (2018-2029)
9.4 Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Region
9.4.1 Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2018-2023)
9.4.3 Asia Diabetic Retinopathy (DR) Analysis Software Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Type
10.2.1 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Application
10.3.1 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Country
10.4.1 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Diabetic Retinopathy (DR) Analysis Software Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Evolucare
11.1.1 Evolucare Company Details
11.1.2 Evolucare Business Overview
11.1.3 Evolucare Diabetic Retinopathy (DR) Analysis Software Introduction
11.1.4 Evolucare Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2018-2023)
11.1.5 Evolucare Recent Developments
11.2 IDx Technologies Inc.
11.2.1 IDx Technologies Inc. Company Details
11.2.2 IDx Technologies Inc. Business Overview
11.2.3 IDx Technologies Inc. Diabetic Retinopathy (DR) Analysis Software Introduction
11.2.4 IDx Technologies Inc. Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2018-2023)
11.2.5 IDx Technologies Inc. Recent Developments
11.3 Yingtong
11.3.1 Yingtong Company Details
11.3.2 Yingtong Business Overview
11.3.3 Yingtong Diabetic Retinopathy (DR) Analysis Software Introduction
11.3.4 Yingtong Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2018-2023)
11.3.5 Yingtong Recent Developments
11.4 Vistel
11.4.1 Vistel Company Details
11.4.2 Vistel Business Overview
11.4.3 Vistel Diabetic Retinopathy (DR) Analysis Software Introduction
11.4.4 Vistel Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2018-2023)
11.4.5 Vistel Recent Developments
11.5 MONA
11.5.1 MONA Company Details
11.5.2 MONA Business Overview
11.5.3 MONA Diabetic Retinopathy (DR) Analysis Software Introduction
11.5.4 MONA Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2018-2023)
11.5.5 MONA Recent Developments
11.6 Eyenuk
11.6.1 Eyenuk Company Details
11.6.2 Eyenuk Business Overview
11.6.3 Eyenuk Diabetic Retinopathy (DR) Analysis Software Introduction
11.6.4 Eyenuk Revenue in Diabetic Retinopathy (DR) Analysis Software Business (2018-2023)
11.6.5 Eyenuk Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Evolucare
IDx Technologies Inc.
Yingtong
Vistel
MONA
Eyenuk
*If Applicable.